Pharmaceuticals news continually updated from thousands of sources around the net.
3 hrs ago | Bioscience Technology
Bristol-Myers Squibb and Pfizer said Thursday that federal regulators have expanded approval of their blood thinner Eliquis to treat two types of dangerous blood clots.
7 hrs ago | The Business Journal
Raptor Pharmaceuticals on Thursday reported that, due to improved second-quarter performance, it would increase its expected net product sales figure for 2014 to between $65 million and $70 million, up from $55 million to $65 million.
10 hrs ago | Business Journal
Organizations have been outsourcing their IT departments for years, but as more and more cloud-based services become available, more companies, particularly those in rural areas, are putting their systems into the hands of larger organizations that can handle the complicated systems.
15 hrs ago | Business Journal
Mitchum spent more than 30 years in the pharmaceutical industry with companies such as Eli Lilly & Co ., Marion Laboratories and Hoechst Marion Roussel in Germany.
19 hrs ago | Sys-Con Media
Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, which is indicated for the treatment of patients with hypokalemia, with or without metabolic alkalosis; in digitalis intoxication; and in patients with hypokalemic familial periodic paralysis.
Cardinal Health CEO Michael C. Kaufmann sold 6,833 shares of the company's stock in a transaction dated Monday, August 18th.
The company's adjustments to financial guidance issued as part of the no-inversion announcement confirmed that the tax inversion enthusiasm was masking weakness in Walgreen's business.
's stock had its "neutral" rating reissued by Credit Suisse in a research note issued on Thursday.
I say haystack because a lot of companies have paid a dividend, be it a regular dividend or special one, over the trailing 12 months -- and not all of those dividends are exactly high quality.
He said while New Jersey remains a central location for pharmaceutical companies, some have departed because of the state's high taxes.
Today, Analysts Review released its research reports regarding Covidien PLC , Mylan, Inc. , Baxter International Inc. , Achillion Pharmaceuticals, Inc. and Perrigo Company PLC .
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
Achillion Pharmaceuticals, Inc. today announced that the U.S. Patent & Trademark Office has granted Achillion U.S. Patent No.
Phase I study to evaluate OPDIVO , Bristol-Myers Squibb's investigational PD-1 immune checkpoint inhibitor, with Celgene's ABRAXANE A for multiple cancers NEW YORK & SUMMIT, N.J.-- -- Bristol-Myers Squibb Company and Celgene Corporation announced today the establishment of a clinical trial collaboration to evaluate the safety, tolerability and ... (more)
Achillion Pharmaceuticals major shareholder Ra Capital Management, Llc sold 4,235,000 shares of the company's stock in a transaction that occurred on Monday, August 18th.
Market highs have been a frequent occurrence so far in 2014, and the healthcare sector has been no stranger to the stock surge.
Updated: Fri Aug 22, 2014 09:04 pm
Copyright © 2014 Topix LLC